The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AI-based pathologic biomarker for pathologic downstaging in patients with muscle-invasive bladder cancer undergoing cystectomy after neoadjuvant nivolumab, gemcitabine, and cisplatin: BLAAST-1 Trial.
 
Viswesh Krishna
Employment - Valar Labs; Valar Labs (I)
Leadership - Valar Labs
Stock and Other Ownership Interests - Valar Labs; Valar Labs (I)
Patents, Royalties, Other Intellectual Property - Valar Labs; Valar Labs (I)
 
Guru P. Sonpavde
Employment - Myriad Genetics (I)
Honoraria - UpToDate
Consulting or Advisory Role - Astellas Pharma; Bicycle Therapeutics; Bristol-Myers Squibb; EMD Serono; Exelixis; G1 Therapeutics; Genentech; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Loxo/Lilly; Lucence; Merck; Pfizer; Scholar Rock; Seagen; Syapse; Vial
Speakers' Bureau - Exelixis; Gilead Sciences; INFORMAÇÃO BRASILEIRA DE ONCOLOGIA; Medscape; Natera; Onclive; Physicans' Education Resource; Research to Practice; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); GeneCentric (Inst); Gilead Sciences (Inst); Jazz Pharmaceuticals (Inst); Predicine (Inst); QED Therapeutics (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
Other Relationship - Astellas Pharma; Bristol-Myers Squibb; Elsevier; G1 Therapeutics; Mereo BioPharma; QED Therapeutics
 
Sumati Gupta
Stock and Other Ownership Interests - Salarius Pharmaceuticals (I)
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Daiichi Sankyo/Lilly (Inst); Five Prime Therapeutics (Inst); Hoosier Cancer Research Network (Inst); Immunocore (Inst); Incyte (Inst); LSK BioPharma (Inst); MedImmune (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); QED Therapeutics (Inst); Rexahn Pharmaceuticals (Inst); Seagen (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - QED Therapeutics
(OPTIONAL) Uncompensated Relationships - Astellas Pharma
 
Benjamin L. Maughan
Consulting or Advisory Role - Astellas Medivation; AVEO; Bavarian Nordic; Bayer; Bristol-Myers Squibb; Clovis Oncology; Exelixis; Janssen Oncology; Merck; Peloton Therapeutics; Pfizer; Tempus
Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Exelixis (Inst)
Travel, Accommodations, Expenses - Exelixis
 
Neeraj Agarwal
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Foundation Medicine; Foundation Medicine; Genentech; Gilead Sciences; Janssen Oncology; Lilly; Lilly; Lilly; Medivation/Astellas; MEI Pharma; Merck; Nektar; Novartis; Pfizer; Pfizer; Pharmacyclics; Seagen
Research Funding - Amgen (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); ORIC Pharmaceuticals (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Takeda (Inst)
 
Markus Eckstein
Employment - Diaceutics
Honoraria - Astellas Pharma; AstraZeneca; Diaceutics; Genomic Health; Janssen-Cilag; Owkin; Roche
Consulting or Advisory Role - AstraZeneca; Diaceutics; Genomic Health; Gilead Sciences; Janssen-Cilag; MSD Oncology; Owkin
Speakers' Bureau - Astellas Pharma; AstraZeneca; Diaceutics; MSD; Roche
Research Funding - AstraZeneca/MedImmune; AstraZeneca/MedImmune; Gilead Sciences; Janssen; Owkin; STRATIFYER Molecular Pathology
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Diaceutics; Genomic Health; Janssen-Cilag; MSD; Roche
 
Matthew Mossanen
Consulting or Advisory Role - Elsevier
Other Relationship - Elsevier
 
Christopher J. Weight
Research Funding - Cisco Systems (Inst); Cisco Systems (Inst); Cleveland Diagnostics (Inst); Johnson and Johnson (Inst)
 
Joaquim Bellmunt
Stock and Other Ownership Interests - Rainier Therapeutics
Honoraria - UpToDate
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech; Merck; Novartis; Pfizer; Pierre Fabre
Research Funding - Millennium (Inst); Pfizer/EMD Serono (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate Bladder Cancer
Travel, Accommodations, Expenses - Ipsen; MSD Oncology; Pfizer
 
Peter C. Black
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Biosyent; Bristol-Myers Squibb; EMD Serono; Ferring; Janssen Oncology; Merck; Minogue Medical; miR Scientific; Nonagen Bioscience; Pfizer; Prokarium; Protara Therapeutics; Protara Therapeutics; QED Therapeutics; Roche Canada; Sanofi; Sesen Bio; STIMIT; TerSera; Tolmar; Urogen pharma; Verity Pharmaceuticals
Speakers' Bureau - Bayer; BioSyent; Pfizer; TerSera
Research Funding - iProgen
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
 
Vladimir Makarov
No Relationships to Disclose
 
C. Marcela Diaz-Montero
No Relationships to Disclose
 
Vrishab Krishna
Employment - Valar Labs; Valar Labs (I)
Leadership - Valar Labs (I)
Stock and Other Ownership Interests - Valar Labs; Valar Labs (I)
Patents, Royalties, Other Intellectual Property - Valar Labs; Valar Labs (I)
 
Waleed Abuzeid
Employment - Valar Labs
Stock and Other Ownership Interests - Valar Labs
Consulting or Advisory Role - Acclarent/Johnson and Johnson
 
Ekin Tiu
Employment - Valar Labs
 
Damir Vrabac
Employment - Valar Labs
Leadership - Valar Labs
Stock and Other Ownership Interests - Valar Labs
Patents, Royalties, Other Intellectual Property - Valar Labs
 
Anirudh Joshi
Employment - Valar Labs
Leadership - Valar Labs
Stock and Other Ownership Interests - Valar Labs
Patents, Royalties, Other Intellectual Property - Valar Labs
 
Pranav Rajpurkar
No Relationships to Disclose
 
Badrinath R. Konety
Stock and Other Ownership Interests - Astrin Biosciences; Styx Biotechnologies
Honoraria - Photocure
Consulting or Advisory Role - Asieris Pharmaceuticals; Convergent biosciences
Research Funding - BMSi (Inst); Pacific Edge Biotechnology (Inst); Photocure (Inst)
Travel, Accommodations, Expenses - Asieris Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Styx Biotechnologies
 
Shilpa Gupta
Stock and Other Ownership Interests - BioNTech SE; Moderna Therapeutics; Nektar; Nektar
Honoraria - Bristol Myers Squibb Foundation
Consulting or Advisory Role - EMD Serono; Foundation Medicine; Gilead Sciences; Guardant Health; Loxo/Lilly; Merck; Natera; Pfizer; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Gilead Sciences; Janssen Oncology; Seagen
Research Funding - Bristol Myers Squibb Foundation (Inst); EMD Serono (Inst); Exelixis (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Merck (Inst); Moderna Therapeutics (Inst); QED Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)